Click for best price
Ocular Hypertension Treatment Market Size, Share 2024
Ocular hypertension is caused by poor drainage of the fluid inside the eye. Essentially, this means that too much fluid enters the eye without being drained, causing high amount of pressure to build up.
This report aims to provide a comprehensive presentation of the global market for Ocular Hypertension Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ocular Hypertension Treatment. This report contains market size and forecasts of Ocular Hypertension Treatment in global, including the following market information:
Global Ocular Hypertension Treatment Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
The global Ocular Hypertension Treatment market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Intraocular Hypertension Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Ocular Hypertension Treatment include Aerie Pharmaceuticals, Inc., Allergan plc, Angelini Group, Chong Kun Dang Pharmaceutical Corp., SALVAT SA, Sophia SA de CV, Lee's Pharmaceutical Holdings Ltd., Neurim Pharmaceuticals Ltd. and NicOx SA, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Ocular Hypertension Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ocular Hypertension Treatment Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Ocular Hypertension Treatment Market Segment Percentages, by Type, 2023 (%)
Intraocular Hypertension
Glaucoma
Global Ocular Hypertension Treatment Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Ocular Hypertension Treatment Market Segment Percentages, by Application, 2023 (%)
Hospitals
Specialty Clinics
Others
Global Ocular Hypertension Treatment Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Ocular Hypertension Treatment Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ocular Hypertension Treatment revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Ocular Hypertension Treatment revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Aerie Pharmaceuticals, Inc.
Allergan plc
Angelini Group
Chong Kun Dang Pharmaceutical Corp.
SALVAT SA
Sophia SA de CV
Lee's Pharmaceutical Holdings Ltd.
Neurim Pharmaceuticals Ltd.
NicOx SA
Novartis AG
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ocular Hypertension Treatment, market overview.
Chapter 2: Global Ocular Hypertension Treatment market size in revenue.
Chapter 3: Detailed analysis of Ocular Hypertension Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ocular Hypertension Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
Report Attributes |
Report Details |
Report Title |
Ocular Hypertension Treatment Market, Global Outlook and Forecast 2024-2030 |
Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
Base Year |
2023 |
Forecast Year |
2031 |
Number of Pages |
69 Pages |
Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Ocular Hypertension Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ocular Hypertension Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ocular Hypertension Treatment Overall Market Size
2.1 Global Ocular Hypertension Treatment Market Size: 2023 VS 2030
2.2 Global Ocular Hypertension Treatment Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Ocular Hypertension Treatment Players in Global Market
3.2 Top Global Ocular Hypertension Treatment Companies Ranked by Revenue
3.3 Global Ocular Hypertension Treatment Revenue by Companies
3.4 Top 3 and Top 5 Ocular Hypertension Treatment Companies in Global Market, by Revenue in 2023
3.5 Global Companies Ocular Hypertension Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Ocular Hypertension Treatment Players in Global Market
3.6.1 List of Global Tier 1 Ocular Hypertension Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Ocular Hypertension Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Ocular Hypertension Treatment Market Size Markets, 2023 & 2030
4.1.2 Intraocular Hypertension
4.1.3 Glaucoma
4.2 By Type - Global Ocular Hypertension Treatment Revenue & Forecasts
4.2.1 By Type - Global Ocular Hypertension Treatment Revenue, 2019-2024
4.2.2 By Type - Global Ocular Hypertension Treatment Revenue, 2025-2030
4.2.3 By Type - Global Ocular Hypertension Treatment Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Ocular Hypertension Treatment Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Specialty Clinics
5.1.4 Others
5.2 By Application - Global Ocular Hypertension Treatment Revenue & Forecasts
5.2.1 By Application - Global Ocular Hypertension Treatment Revenue, 2019-2024
5.2.2 By Application - Global Ocular Hypertension Treatment Revenue, 2025-2030
5.2.3 By Application - Global Ocular Hypertension Treatment Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Ocular Hypertension Treatment Market Size, 2023 & 2030
6.2 By Region - Global Ocular Hypertension Treatment Revenue & Forecasts
6.2.1 By Region - Global Ocular Hypertension Treatment Revenue, 2019-2024
6.2.2 By Region - Global Ocular Hypertension Treatment Revenue, 2025-2030
6.2.3 By Region - Global Ocular Hypertension Treatment Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Ocular Hypertension Treatment Revenue, 2019-2030
6.3.2 US Ocular Hypertension Treatment Market Size, 2019-2030
6.3.3 Canada Ocular Hypertension Treatment Market Size, 2019-2030
6.3.4 Mexico Ocular Hypertension Treatment Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Ocular Hypertension Treatment Revenue, 2019-2030
6.4.2 Germany Ocular Hypertension Treatment Market Size, 2019-2030
6.4.3 France Ocular Hypertension Treatment Market Size, 2019-2030
6.4.4 U.K. Ocular Hypertension Treatment Market Size, 2019-2030
6.4.5 Italy Ocular Hypertension Treatment Market Size, 2019-2030
6.4.6 Russia Ocular Hypertension Treatment Market Size, 2019-2030
6.4.7 Nordic Countries Ocular Hypertension Treatment Market Size, 2019-2030
6.4.8 Benelux Ocular Hypertension Treatment Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Ocular Hypertension Treatment Revenue, 2019-2030
6.5.2 China Ocular Hypertension Treatment Market Size, 2019-2030
6.5.3 Japan Ocular Hypertension Treatment Market Size, 2019-2030
6.5.4 South Korea Ocular Hypertension Treatment Market Size, 2019-2030
6.5.5 Southeast Asia Ocular Hypertension Treatment Market Size, 2019-2030
6.5.6 India Ocular Hypertension Treatment Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Ocular Hypertension Treatment Revenue, 2019-2030
6.6.2 Brazil Ocular Hypertension Treatment Market Size, 2019-2030
6.6.3 Argentina Ocular Hypertension Treatment Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Ocular Hypertension Treatment Revenue, 2019-2030
6.7.2 Turkey Ocular Hypertension Treatment Market Size, 2019-2030
6.7.3 Israel Ocular Hypertension Treatment Market Size, 2019-2030
6.7.4 Saudi Arabia Ocular Hypertension Treatment Market Size, 2019-2030
6.7.5 UAE Ocular Hypertension Treatment Market Size, 2019-2030
7 Ocular Hypertension Treatment Companies Profiles
7.1 Aerie Pharmaceuticals, Inc.
7.1.1 Aerie Pharmaceuticals, Inc. Company Summary
7.1.2 Aerie Pharmaceuticals, Inc. Business Overview
7.1.3 Aerie Pharmaceuticals, Inc. Ocular Hypertension Treatment Major Product Offerings
7.1.4 Aerie Pharmaceuticals, Inc. Ocular Hypertension Treatment Revenue in Global Market (2019-2024)
7.1.5 Aerie Pharmaceuticals, Inc. Key News & Latest Developments
7.2 Allergan plc
7.2.1 Allergan plc Company Summary
7.2.2 Allergan plc Business Overview
7.2.3 Allergan plc Ocular Hypertension Treatment Major Product Offerings
7.2.4 Allergan plc Ocular Hypertension Treatment Revenue in Global Market (2019-2024)
7.2.5 Allergan plc Key News & Latest Developments
7.3 Angelini Group
7.3.1 Angelini Group Company Summary
7.3.2 Angelini Group Business Overview
7.3.3 Angelini Group Ocular Hypertension Treatment Major Product Offerings
7.3.4 Angelini Group Ocular Hypertension Treatment Revenue in Global Market (2019-2024)
7.3.5 Angelini Group Key News & Latest Developments
7.4 Chong Kun Dang Pharmaceutical Corp.
7.4.1 Chong Kun Dang Pharmaceutical Corp. Company Summary
7.4.2 Chong Kun Dang Pharmaceutical Corp. Business Overview
7.4.3 Chong Kun Dang Pharmaceutical Corp. Ocular Hypertension Treatment Major Product Offerings
7.4.4 Chong Kun Dang Pharmaceutical Corp. Ocular Hypertension Treatment Revenue in Global Market (2019-2024)
7.4.5 Chong Kun Dang Pharmaceutical Corp. Key News & Latest Developments
7.5 SALVAT SA
7.5.1 SALVAT SA Company Summary
7.5.2 SALVAT SA Business Overview
7.5.3 SALVAT SA Ocular Hypertension Treatment Major Product Offerings
7.5.4 SALVAT SA Ocular Hypertension Treatment Revenue in Global Market (2019-2024)
7.5.5 SALVAT SA Key News & Latest Developments
7.6 Sophia SA de CV
7.6.1 Sophia SA de CV Company Summary
7.6.2 Sophia SA de CV Business Overview
7.6.3 Sophia SA de CV Ocular Hypertension Treatment Major Product Offerings
7.6.4 Sophia SA de CV Ocular Hypertension Treatment Revenue in Global Market (2019-2024)
7.6.5 Sophia SA de CV Key News & Latest Developments
7.7 Lee's Pharmaceutical Holdings Ltd.
7.7.1 Lee's Pharmaceutical Holdings Ltd. Company Summary
7.7.2 Lee's Pharmaceutical Holdings Ltd. Business Overview
7.7.3 Lee's Pharmaceutical Holdings Ltd. Ocular Hypertension Treatment Major Product Offerings
7.7.4 Lee's Pharmaceutical Holdings Ltd. Ocular Hypertension Treatment Revenue in Global Market (2019-2024)
7.7.5 Lee's Pharmaceutical Holdings Ltd. Key News & Latest Developments
7.8 Neurim Pharmaceuticals Ltd.
7.8.1 Neurim Pharmaceuticals Ltd. Company Summary
7.8.2 Neurim Pharmaceuticals Ltd. Business Overview
7.8.3 Neurim Pharmaceuticals Ltd. Ocular Hypertension Treatment Major Product Offerings
7.8.4 Neurim Pharmaceuticals Ltd. Ocular Hypertension Treatment Revenue in Global Market (2019-2024)
7.8.5 Neurim Pharmaceuticals Ltd. Key News & Latest Developments
7.9 NicOx SA
7.9.1 NicOx SA Company Summary
7.9.2 NicOx SA Business Overview
7.9.3 NicOx SA Ocular Hypertension Treatment Major Product Offerings
7.9.4 NicOx SA Ocular Hypertension Treatment Revenue in Global Market (2019-2024)
7.9.5 NicOx SA Key News & Latest Developments
7.10 Novartis AG
7.10.1 Novartis AG Company Summary
7.10.2 Novartis AG Business Overview
7.10.3 Novartis AG Ocular Hypertension Treatment Major Product Offerings
7.10.4 Novartis AG Ocular Hypertension Treatment Revenue in Global Market (2019-2024)
7.10.5 Novartis AG Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Ocular Hypertension Treatment Market Opportunities & Trends in Global Market
Table 2. Ocular Hypertension Treatment Market Drivers in Global Market
Table 3. Ocular Hypertension Treatment Market Restraints in Global Market
Table 4. Key Players of Ocular Hypertension Treatment in Global Market
Table 5. Top Ocular Hypertension Treatment Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Ocular Hypertension Treatment Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Ocular Hypertension Treatment Revenue Share by Companies, 2019-2024
Table 8. Global Companies Ocular Hypertension Treatment Product Type
Table 9. List of Global Tier 1 Ocular Hypertension Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ocular Hypertension Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Ocular Hypertension Treatment Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Ocular Hypertension Treatment Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Ocular Hypertension Treatment Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Ocular Hypertension Treatment Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Ocular Hypertension Treatment Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Ocular Hypertension Treatment Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Ocular Hypertension Treatment Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Ocular Hypertension Treatment Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Ocular Hypertension Treatment Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Ocular Hypertension Treatment Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Ocular Hypertension Treatment Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Ocular Hypertension Treatment Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Ocular Hypertension Treatment Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Ocular Hypertension Treatment Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Ocular Hypertension Treatment Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Ocular Hypertension Treatment Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Ocular Hypertension Treatment Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Ocular Hypertension Treatment Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Ocular Hypertension Treatment Revenue, (US$, Mn), 2025-2030
Table 30. Aerie Pharmaceuticals, Inc. Company Summary
Table 31. Aerie Pharmaceuticals, Inc. Ocular Hypertension Treatment Product Offerings
Table 32. Aerie Pharmaceuticals, Inc. Ocular Hypertension Treatment Revenue (US$, Mn) & (2019-2024)
Table 33. Aerie Pharmaceuticals, Inc. Key News & Latest Developments
Table 34. Allergan plc Company Summary
Table 35. Allergan plc Ocular Hypertension Treatment Product Offerings
Table 36. Allergan plc Ocular Hypertension Treatment Revenue (US$, Mn) & (2019-2024)
Table 37. Allergan plc Key News & Latest Developments
Table 38. Angelini Group Company Summary
Table 39. Angelini Group Ocular Hypertension Treatment Product Offerings
Table 40. Angelini Group Ocular Hypertension Treatment Revenue (US$, Mn) & (2019-2024)
Table 41. Angelini Group Key News & Latest Developments
Table 42. Chong Kun Dang Pharmaceutical Corp. Company Summary
Table 43. Chong Kun Dang Pharmaceutical Corp. Ocular Hypertension Treatment Product Offerings
Table 44. Chong Kun Dang Pharmaceutical Corp. Ocular Hypertension Treatment Revenue (US$, Mn) & (2019-2024)
Table 45. Chong Kun Dang Pharmaceutical Corp. Key News & Latest Developments
Table 46. SALVAT SA Company Summary
Table 47. SALVAT SA Ocular Hypertension Treatment Product Offerings
Table 48. SALVAT SA Ocular Hypertension Treatment Revenue (US$, Mn) & (2019-2024)
Table 49. SALVAT SA Key News & Latest Developments
Table 50. Sophia SA de CV Company Summary
Table 51. Sophia SA de CV Ocular Hypertension Treatment Product Offerings
Table 52. Sophia SA de CV Ocular Hypertension Treatment Revenue (US$, Mn) & (2019-2024)
Table 53. Sophia SA de CV Key News & Latest Developments
Table 54. Lee's Pharmaceutical Holdings Ltd. Company Summary
Table 55. Lee's Pharmaceutical Holdings Ltd. Ocular Hypertension Treatment Product Offerings
Table 56. Lee's Pharmaceutical Holdings Ltd. Ocular Hypertension Treatment Revenue (US$, Mn) & (2019-2024)
Table 57. Lee's Pharmaceutical Holdings Ltd. Key News & Latest Developments
Table 58. Neurim Pharmaceuticals Ltd. Company Summary
Table 59. Neurim Pharmaceuticals Ltd. Ocular Hypertension Treatment Product Offerings
Table 60. Neurim Pharmaceuticals Ltd. Ocular Hypertension Treatment Revenue (US$, Mn) & (2019-2024)
Table 61. Neurim Pharmaceuticals Ltd. Key News & Latest Developments
Table 62. NicOx SA Company Summary
Table 63. NicOx SA Ocular Hypertension Treatment Product Offerings
Table 64. NicOx SA Ocular Hypertension Treatment Revenue (US$, Mn) & (2019-2024)
Table 65. NicOx SA Key News & Latest Developments
Table 66. Novartis AG Company Summary
Table 67. Novartis AG Ocular Hypertension Treatment Product Offerings
Table 68. Novartis AG Ocular Hypertension Treatment Revenue (US$, Mn) & (2019-2024)
Table 69. Novartis AG Key News & Latest Developments
List of Figures
Figure 1. Ocular Hypertension Treatment Segment by Type in 2023
Figure 2. Ocular Hypertension Treatment Segment by Application in 2023
Figure 3. Global Ocular Hypertension Treatment Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Ocular Hypertension Treatment Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Ocular Hypertension Treatment Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Ocular Hypertension Treatment Revenue in 2023
Figure 8. By Type - Global Ocular Hypertension Treatment Revenue Market Share, 2019-2030
Figure 9. By Application - Global Ocular Hypertension Treatment Revenue Market Share, 2019-2030
Figure 10. By Type - Global Ocular Hypertension Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Ocular Hypertension Treatment Revenue Market Share, 2019-2030
Figure 12. By Application - Global Ocular Hypertension Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Ocular Hypertension Treatment Revenue Market Share, 2019-2030
Figure 14. By Region - Global Ocular Hypertension Treatment Revenue Market Share, 2019-2030
Figure 15. By Country - North America Ocular Hypertension Treatment Revenue Market Share, 2019-2030
Figure 16. US Ocular Hypertension Treatment Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Ocular Hypertension Treatment Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Ocular Hypertension Treatment Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Ocular Hypertension Treatment Revenue Market Share, 2019-2030
Figure 20. Germany Ocular Hypertension Treatment Revenue, (US$, Mn), 2019-2030
Figure 21. France Ocular Hypertension Treatment Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Ocular Hypertension Treatment Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Ocular Hypertension Treatment Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Ocular Hypertension Treatment Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Ocular Hypertension Treatment Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Ocular Hypertension Treatment Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Ocular Hypertension Treatment Revenue Market Share, 2019-2030
Figure 28. China Ocular Hypertension Treatment Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Ocular Hypertension Treatment Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Ocular Hypertension Treatment Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Ocular Hypertension Treatment Revenue, (US$, Mn), 2019-2030
Figure 32. India Ocular Hypertension Treatment Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Ocular Hypertension Treatment Revenue Market Share, 2019-2030
Figure 34. Brazil Ocular Hypertension Treatment Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Ocular Hypertension Treatment Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Ocular Hypertension Treatment Revenue Market Share, 2019-2030
Figure 37. Turkey Ocular Hypertension Treatment Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Ocular Hypertension Treatment Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Ocular Hypertension Treatment Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Ocular Hypertension Treatment Revenue, (US$, Mn), 2019-2030
Figure 41. Aerie Pharmaceuticals, Inc. Ocular Hypertension Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Allergan plc Ocular Hypertension Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Angelini Group Ocular Hypertension Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Chong Kun Dang Pharmaceutical Corp. Ocular Hypertension Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. SALVAT SA Ocular Hypertension Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Sophia SA de CV Ocular Hypertension Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Lee's Pharmaceutical Holdings Ltd. Ocular Hypertension Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Neurim Pharmaceuticals Ltd. Ocular Hypertension Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. NicOx SA Ocular Hypertension Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Novartis AG Ocular Hypertension Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)